These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9751705)

  • 1. Characterization of covalent adriamycin-DNA adducts.
    Zeman SM; Phillips DR; Crothers DM
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11561-5. PubMed ID: 9751705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of formaldehyde and DNA-adriamycin or DNA-daunomycin adducts, initiated through redox chemistry of dithiothreitol/iron, xanthine oxidase/NADH/iron, or glutathione/iron.
    Taatjes DJ; Gaudiano G; Koch TH
    Chem Res Toxicol; 1997 Sep; 10(9):953-61. PubMed ID: 9305576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of formaldehyde-mediated covalent adducts of adriamycin with DNA.
    Luce RA; Sigurdsson ST; Hopkins PB
    Biochemistry; 1999 Jul; 38(27):8682-90. PubMed ID: 10393543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox pathway leading to the alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin.
    Taatjes DJ; Gaudiano G; Resing K; Koch TH
    J Med Chem; 1997 Apr; 40(8):1276-86. PubMed ID: 9111302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barminomycin functions as a potent pre-activated analogue of Adriamycin.
    Moufarij MA; Cutts SM; Neumann GM; Kimura K; Phillips DR
    Chem Biol Interact; 2001 Nov; 138(2):137-53. PubMed ID: 11672697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence specificity of adriamycin-DNA adducts in human tumor cells.
    Cutts SM; Swift LP; Rephaeli A; Nudelman A; Phillips DR
    Mol Cancer Ther; 2003 Jul; 2(7):661-70. PubMed ID: 12883039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pixantrone can be activated by formaldehyde to generate a potent DNA adduct forming agent.
    Evison BJ; Mansour OC; Menta E; Phillips DR; Cutts SM
    Nucleic Acids Res; 2007; 35(11):3581-9. PubMed ID: 17483512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitosene-DNA adducts. Characterization of two major DNA monoadducts formed by 1,10-bis(acetoxy)-7-methoxymitosene upon reductive activation.
    Maliepaard M; de Mol NJ; Tomasz M; Gargiulo D; Janssen LH; van Duynhoven JP; van Velzen EJ; Verboom W; Reinhoudt DN
    Biochemistry; 1997 Jul; 36(30):9211-20. PubMed ID: 9230054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Therapeutic Advantages of Doxorubicin when Activated by Formaldehyde to Function as a DNA Adduct-Forming Agent.
    Cutts SM; Rephaeli A; Nudelman A; Ugarenko M; Phillips DR
    Curr Top Med Chem; 2015; 15(14):1409-22. PubMed ID: 25866273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The power and potential of doxorubicin-DNA adducts.
    Cutts SM; Nudelman A; Rephaeli A; Phillips DR
    IUBMB Life; 2005 Feb; 57(2):73-81. PubMed ID: 16036566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formaldehyde-releasing prodrugs in combination with adriamycin can overcome cellular drug resistance.
    Cutts SM; Nudelman A; Pillay V; Spencer DM; Levovich I; Rephaeli A; Phillips DR
    Oncol Res; 2005; 15(4):199-213. PubMed ID: 17822280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of adriamycin by the pH-dependent formaldehyde-releasing prodrug hexamethylenetetramine.
    Swift LP; Cutts SM; Rephaeli A; Nudelman A; Phillips DR
    Mol Cancer Ther; 2003 Feb; 2(2):189-98. PubMed ID: 12589036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of adriamycin--DNA adducts in vitro.
    Cullinane C; Cutts SM; van Rosmalen A; Phillips DR
    Nucleic Acids Res; 1994 Jun; 22(12):2296-303. PubMed ID: 8036157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations.
    Coldwell KE; Cutts SM; Ognibene TJ; Henderson PT; Phillips DR
    Nucleic Acids Res; 2008 Sep; 36(16):e100. PubMed ID: 18632763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long range 1,4 and 1,6-interstrand cross-links formed by a trinuclear platinum complex. Minor groove preassociation affects kinetics and mechanism of cross-link formation as well as adduct structure.
    Hegmans A; Berners-Price SJ; Davies MS; Thomas DS; Humphreys AS; Farrell N
    J Am Chem Soc; 2004 Feb; 126(7):2166-80. PubMed ID: 14971952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of DNA adducts by formaldehyde-activated mitoxantrone.
    Parker BS; Cullinane C; Phillips DR
    Nucleic Acids Res; 1999 Jul; 27(14):2918-23. PubMed ID: 10390534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution structure of the (+)-cis-anti-benzo[a]pyrene-dA ([BP]dA) adduct opposite dT in a DNA duplex.
    Mao B; Gu Z; Gorin A; Chen J; Hingerty BE; Amin S; Broyde S; Geacintov NE; Patel DJ
    Biochemistry; 1999 Aug; 38(33):10831-42. PubMed ID: 10451380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formaldehyde-activated Pixantrone is a monofunctional DNA alkylator that binds selectively to CpG and CpA doublets.
    Evison BJ; Chiu F; Pezzoni G; Phillips DR; Cutts SM
    Mol Pharmacol; 2008 Jul; 74(1):184-94. PubMed ID: 18413664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Base selectivity and effects of sequence and DNA secondary structure on the formation of covalent adducts derived from the equine estrogen metabolite 4-hydroxyequilenin.
    Kolbanovskiy A; Kuzmin V; Shastry A; Kolbanovskaya M; Chen D; Chang M; Bolton JL; Geacintov NE
    Chem Res Toxicol; 2005 Nov; 18(11):1737-47. PubMed ID: 16300383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of covalent ellipticine- and doxorubicin-derived adducts in DNA of neuroblastoma cells by the ³²P-postlabeling technique.
    Stiborova M; Poljakova J; Eckschlager T; Kizek R; Frei E
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Jun; 156(2):115-21. PubMed ID: 22837132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.